Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study

BACKGROUND: In critically ill patients the incidence of invasive fungal infections caused by Candida spp. has increased remarkably. Echinocandins are recommended as initial treatment for invasive fungal infections. The safety and efficacy of micafungin compared to caspofungin is similar, but no comp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Infect Dis
Glavni autori: van der Geest, Patrick J., Hunfeld, Nicole G. M., Ladage, Sophie E., Groeneveld, A. B. Johan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5025542/
https://ncbi.nlm.nih.gov/pubmed/27634140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-1825-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items